Option Care Health (OPCH) AGM 2026 summary
Event summary combining transcript, slides, and related documents.
AGM 2026 summary
21 May, 2026Opening remarks and agenda
Meeting opened with acknowledgments to outgoing board members for their decade of service and strategic oversight.
Agenda and rules of conduct were made available online, with instructions for voting and submitting questions.
Board and executive committee updates
Nine director nominees were presented for election, with board recommendation to vote for each.
Two long-serving directors, Elizabeth Betten and David Golding, departed from the board.
Shareholder proposals
No additional proposals or nominations were introduced beyond those in the proxy statement.
Partial view of Summaries dataset, powered by Quartr API
Latest events from Option Care Health
- Delivered strong 2026 growth with $1.44B Q2 revenue and national home infusion leadership.OPCH
Investor presentation - Q2 2026 delivered higher revenue, earnings, and cash flow, with strong acute therapy growth.OPCH
Q2 2026 - Balanced growth, payer partnerships, and strong cash flow drive expansion and resilience.OPCH
Bank of America 2025 Healthcare Conference - Growth outlook remains strong despite STELARA headwinds, with raised 2025 guidance and robust execution.OPCH
UBS Global Healthcare Conference 2025 - Sustained growth driven by home infusion demand, diversified portfolio, and strong financials.OPCH
Investor presentation - Q3 revenue up 17% but net income down 4.3% as supply chain and pricing issues weigh on results.OPCH
Q3 2024 - Q2 revenue up 14.8%, net income down 53.6%, guidance raised, and cash flow strong.OPCH
Q2 2024 - Strong growth, strategic expansion, and resilient operations drive outlook for 2025.OPCH
43rd Annual J.P. Morgan Healthcare Conference 2025 - Q4 revenue rose 19.7% and 2025 guidance signals continued earnings growth.OPCH
Q4 2024